Patents by Inventor Ingrid Langsetmo

Ingrid Langsetmo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT
    Publication number: 20240325487
    Abstract: Provided are non-NHE3-binding agents having activity as phosphate transport/uptake inhibitors in the gastrointestinal tract, including in the small intestine, methods for their use as therapeutic or prophylactic agents, and related methods of drug discovery.
    Type: Application
    Filed: October 19, 2023
    Publication date: October 3, 2024
    Inventors: Dominique Charmot, Jason G. Lewis, Jeffrey W. Jacobs, Ingrid Langsetmo, Christopher Carreras
  • Compounds and methods for inhibiting phosphate transport
    Patent number: 11813304
    Abstract: Provided are non-NHE3-binding agents having activity as phosphate transport/uptake inhibitors in the gastrointestinal tract, including in the small intestine, methods for their use as therapeutic or prophylactic agents, and related methods of drug discovery.
    Type: Grant
    Filed: July 15, 2019
    Date of Patent: November 14, 2023
    Assignee: Ardelyx, Inc.
    Inventors: Dominique Charmot, Jason G. Lewis, Jeffrey W. Jacobs, Ingrid Langsetmo, Christopher Carreras
  • COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT
    Publication number: 20200038475
    Abstract: Provided are non-NHE3-binding agents having activity as phosphate transport/uptake inhibitors in the gastrointestinal tract, including in the small intestine, methods for their use as therapeutic or prophylactic agents, and related methods of drug discovery.
    Type: Application
    Filed: July 15, 2019
    Publication date: February 6, 2020
    Applicant: Ardelyx, Inc.
    Inventors: Dominique Charmot, Jason G. Lewis, Jeffrey W. Jacobs, Ingrid Langsetmo, Christopher Carreras
  • Compositions and methods for treating hyperkalemia
    Patent number: 9919006
    Abstract: The present invention is directed to compositions and methods of removing potassium or treating hyperkalemia by administering pharmaceutical compositions of cation exchange polymers with low crosslinking for improved potassium excretion and for beneficial physical properties to increase patient compliance.
    Type: Grant
    Filed: July 29, 2016
    Date of Patent: March 20, 2018
    Assignee: Ardelyx, Inc.
    Inventors: Dominique Charmot, James P. Davidson, Fangling Lin, Jeffrey W. Jacobs, Natalia Blinova, Eric Labonte, Ingrid Langsetmo, Robert C. Blanks
  • COMPOSITIONS AND METHODS FOR TREATING HYPERKALEMIA
    Publication number: 20180064751
    Abstract: The present invention is directed to compositions and methods of removing potassium or treating hyperkalemia by administering pharmaceutical compositions of cation exchange polymers with low crosslinking for improved potassium excretion and for beneficial physical properties to increase patient compliance.
    Type: Application
    Filed: April 14, 2017
    Publication date: March 8, 2018
    Inventors: Dominique Charmot, James P. Davidson, Fangling Lin, Jeffrey W. Jacobs, Natalia Blinova, Eric Labonte, Ingrid Langsetmo, Robert C. Blanks
  • Compositions and methods for treating hyperkalemia
    Patent number: 9867848
    Abstract: The present invention is directed to compositions and methods of removing potassium or treating hyperkalemia by administering pharmaceutical compositions of cation exchange polymers with low crosslinking for improved potassium excretion and for beneficial physical properties to increase patient compliance.
    Type: Grant
    Filed: March 29, 2017
    Date of Patent: January 16, 2018
    Assignee: ARDELYX, INC.
    Inventors: Dominique Charmot, James P. Davidson, Fangling Lin, Jeffrey W. Jacobs, Natalia Blinova, Eric Labonte, Ingrid Langsetmo, Robert C. Blanks
  • COMPOSITIONS AND METHODS FOR TREATING HYPERKALEMIA
    Publication number: 20170196903
    Abstract: The present invention is directed to compositions and methods of removing potassium or treating hyperkalemia by administering pharmaceutical compositions of cation exchange polymers with low crosslinking for improved potassium excretion and for beneficial physical properties to increase patient compliance.
    Type: Application
    Filed: March 29, 2017
    Publication date: July 13, 2017
    Inventors: Dominique Charmot, James P. Davidson, Fangling Lin, Jeffrey W. Jacobs, Natalia Blinova, Eric Labonte, Ingrid Langsetmo, Robert C. Blanks
  • COMPOSITIONS AND METHODS FOR TREATING HYPERKALEMIA
    Publication number: 20170173072
    Abstract: The present invention is directed to compositions and methods of removing potassium or treating hyperkalemia by administering pharmaceutical compositions of cation exchange polymers with low crosslinking for improved potassium excretion and for beneficial physical properties to increase patient compliance.
    Type: Application
    Filed: July 29, 2016
    Publication date: June 22, 2017
    Inventors: Dominique Charmot, James P. Davidson, Fangling Lin, Jeffrey W. Jacobs, Natalia Blinova, Eric Labonte, Ingrid Langsetmo, Robert C. Blanks
  • Compositions and methods for treating hyperkalemia
    Patent number: 9655921
    Abstract: The present invention is directed to compositions and methods of removing potassium or treating hyperkalemia by administering pharmaceutical compositions of cation exchange polymers with low crosslinking for improved potassium excretion and for beneficial physical properties to increase patient compliance.
    Type: Grant
    Filed: December 22, 2015
    Date of Patent: May 23, 2017
    Assignee: Ardelyx, Inc.
    Inventors: Dominique Charmot, James P. Davidson, Fangling Lin, Jeffrey W. Jacobs, Natalia Blinova, Eric Labonte, Ingrid Langsetmo, Robert C. Blanks
  • Pharmaceutical compositions for treating hyperkalemia
    Patent number: 9549947
    Abstract: The present invention is directed to compositions and methods of removing potassium or treating hyperkalemia by administering pharmaceutical compositions of cation exchange polymers with low crosslinking for improved potassium excretion and for beneficial physical properties to increase patient compliance.
    Type: Grant
    Filed: February 24, 2016
    Date of Patent: January 24, 2017
    Assignee: Ardelyx, Inc.
    Inventors: Dominique Charmot, James P. Davidson, Fangling Lin, Jeffrey W. Jacobs, Natalia Blinova, Eric Labonte, Ingrid Langsetmo, Robert C. Blanks
  • Pharmaceutical compositions for treating hyperkalemia
    Patent number: 9545425
    Abstract: The present invention is directed to compositions and methods of removing potassium or treating hyperkalemia by administering pharmaceutical compositions of cation exchange polymers with low crosslinking for improved potassium excretion and for beneficial physical properties to increase patient compliance.
    Type: Grant
    Filed: February 24, 2016
    Date of Patent: January 17, 2017
    Assignee: Ardelyx, Inc.
    Inventors: Dominique Charmot, James P. Davidson, Fangling Lin, Jeffrey W. Jacobs, Natalia Blinova, Eric Labonte, Ingrid Langsetmo, Robert C. Blanks
  • COMPOSITIONS AND METHODS FOR TREATING HYPERKALEMIA
    Publication number: 20160346318
    Abstract: The present invention is directed to compositions and methods of removing potassium or treating hyperkalemia by administering pharmaceutical compositions of cation exchange polymers with low crosslinking for improved potassium excretion and for beneficial physical properties to increase patient compliance.
    Type: Application
    Filed: December 22, 2015
    Publication date: December 1, 2016
    Inventors: Dominique Charmot, James P. Davidson, Fangling Lin, Jeffrey W. Jacobs, Natalia Blinova, Eric Labonte, Ingrid Langsetmo, Robert C. Blanks
  • Compositions and methods for treating hyperkalemia
    Patent number: 9433640
    Abstract: The present invention is directed to compositions and methods of removing potassium or treating hyperkalemia by administering pharmaceutical compositions of cation exchange polymers with low crosslinking for improved potassium excretion and for beneficial physical properties to increase patient compliance.
    Type: Grant
    Filed: February 24, 2016
    Date of Patent: September 6, 2016
    Assignee: Ardelyx, Inc.
    Inventors: Dominique Charmot, James P. Davidson, Fangling Lin, Jeffrey W. Jacobs, Natalia Blinova, Eric Labonte, Ingrid Langsetmo, Robert C. Blanks
  • COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT
    Publication number: 20160184387
    Abstract: Provided are non-NHE3-binding agents having activity as phosphate transport/uptake inhibitors in the gastrointestinal tract, including in the small intestine, methods for their use as therapeutic or prophylactic agents, and related methods of drug discovery.
    Type: Application
    Filed: August 8, 2014
    Publication date: June 30, 2016
    Inventors: Dominique CHARMOT, Jason G. LEWIS, Jeffrey W. JACOBS, Ingrid LANGSETMO, Christopher RERAS
  • COMPOSITIONS AND METHODS FOR TREATING HYPERKALEMIA
    Publication number: 20160175344
    Abstract: The present invention is directed to compositions and methods of removing potassium or treating hyperkalemia by administering pharmaceutical compositions of cation exchange polymers with low crosslinking for improved potassium excretion and for beneficial physical properties to increase patient compliance.
    Type: Application
    Filed: February 24, 2016
    Publication date: June 23, 2016
    Inventors: Dominique Charmot, James P. Davidson, Fangling Lin, Jeffrey W. Jacobs, Natalia Blinova, Eric Labonte, Ingrid Langsetmo, Robert C. Blanks
  • PHARMACEUTICAL COMPOSITIONS FOR TREATING HYPERKALEMIA
    Publication number: 20160175346
    Abstract: The present invention is directed to compositions and methods of removing potassium or treating hyperkalemia by administering pharmaceutical compositions of cation exchange polymers with low crosslinking for improved potassium excretion and for beneficial physical properties to increase patient compliance.
    Type: Application
    Filed: February 24, 2016
    Publication date: June 23, 2016
    Inventors: Dominique Charmot, James P. Davidson, Fangling Lin, Jeffrey W. Jacobs, Natalia Blinova, Eric Labonte, Ingrid Langsetmo, Robert C. Blanks
  • PHARMACEUTICAL COMPOSITIONS FOR TREATING HYPERKALEMIA
    Publication number: 20160175345
    Abstract: The present invention is directed to compositions and methods of removing potassium or treating hyperkalemia by administering pharmaceutical compositions of cation exchange polymers with low crosslinking for improved potassium excretion and for beneficial physical properties to increase patient compliance.
    Type: Application
    Filed: February 24, 2016
    Publication date: June 23, 2016
    Inventors: Dominique Charmot, James P. Davidson, Fangling Lin, Jeffrey W. Jacobs, Natalia Blinova, Eric Labonte, Ingrid Langsetmo, Robert C. Blanks